Try a new search

Format these results:

Searched for:

in-biosketch:true

person:bangas01

Total Results:

827


Assessment of Revascularization Preferences with Best-Worst Scaling Among Patients with Ischemic Heart Disease

Mukhopadhyay, Amrita; Dickson, Victoria Vaughan; Langford, Aisha; Spertus, John A; Bangalore, Sripal; Zhang, Yan; Tarpey, Thaddeus; Hochman, Judith; Katz, Stuart D
PMID: 39423941
ISSN: 1532-8414
CID: 5718902

Comparing upfront catheter-based thrombectomy with alternative treatment strategies for clot-in-transit

Zhang, Robert S; Maqsood, Muhammad; Yuriditsky, Eugene; Zhang, Peter; Elbaum, Lindsay; Greco, Allison A; Mukherjee, Vikramjit; Postelnicu, Radu; Alviar, Carlos L; Bangalore, Sripal
PMID: 39172883
ISSN: 1557-2501
CID: 5680962

Percutaneous mechanical thrombectomy in acute pulmonary embolism: Outcomes from a safety-net hospital

Zhang, Robert S; Alviar, Carlos L; Yuriditsky, Eugene; Alam, Usman; Zhang, Peter S; Elbaum, Lindsay; Grossman, Kelsey; Singh, Arushi; Maqsood, Muhammad H; Greco, Allison A; Postelnicu, Radu; Mukherjee, Vikramjit; Horowitz, James; Keller, Norma; Bangalore, Sripal
BACKGROUND:Our study aims to present clinical outcomes of mechanical thrombectomy (MT) in a safety-net hospital. METHODS:This is a retrospective study of intermediate or high-risk pulmonary embolism (PE) patients who underwent MT between October 2020 and May 2023. The primary outcome was 30-day mortality. RESULTS:Among 61 patients (mean age 57.6 years, 47% women, 57% Black) analyzed, 12 (19.7%) were classified as high-risk PE, and 49 (80.3%) were intermediate-risk PE. Of these patients, 62.3% had Medicaid or were uninsured, 50.8% lived in a high poverty zip code. The prevalence of normotensive shock in intermediate-risk PE patients was 62%. Immediate hemodynamic improvements included 7.4 mmHg mean drop in mean pulmonary artery pressure (-21.7%, p < 0.001) and 93% had normalization of their cardiac index postprocedure. Thirty-day mortality for the entire cohort was 5% (3 patients) and 0% when restricted to the intermediate-risk group. All 3 patients who died at 30 days presented with cardiac arrest. There were no differences in short-term mortality based on race, insurance type, citizenship status, or socioeconomic status. All-cause mortality at most recent follow up was 13.1% (mean follow up time of 13.4 ± 8.5 months). CONCLUSION:We extend the findings from prior studies that MT demonstrates a favorable safety profile with immediate improvement in hemodynamics and a low 30-day mortality in patients with acute PE, holding true even with relatively higher risk and more vulnerable population within a safety-net hospital.
PMID: 38577945
ISSN: 1522-726x
CID: 5931202

Use of Multimodal Imaging for Diagnosis and Management of Pulmonary Artery Sarcoma Mimicking as Acute Pulmonary Embolism [Case Report]

Cerezo, Juan; Cohen, Rachel; Banco, Darcy; Yongue, Camille; Hena, Kerry; Bangalore, Sripal; Chan, Justin C Y
Pulmonary artery sarcoma is a rare intravascular tumor that mimics pulmonary embolus. Early recognition and referral to surgery is important because nonsurgically treated tumors have a poor prognosis. Here, we describe a case of pulmonary artery sarcoma diagnosed with multimodal imaging, which also aided in surgical planning.
PMCID:11602593
PMID: 39619039
ISSN: 2666-0849
CID: 5804262

Right Ventricular-Pulmonary Arterial Uncoupling as a Predictor of Invasive Hemodynamics and Normotensive Shock in Acute Pulmonary Embolism

Yuriditsky, Eugene; Zhang, Robert S; Zhang, Peter; Postelnicu, Radu; Greco, Allison A; Horowitz, James M; Bernard, Samuel; Leiva, Orly; Mukherjee, Vikramjit; Hena, Kerry; Elbaum, Lindsay; Alviar, Carlos L; Keller, Norma M; Bangalore, Sripal
Right ventricular-pulmonary arterial coupling describes the relation between right ventricular contractility and its afterload and is estimated as the ratio of the tricuspid annular plane systolic excursion (TAPSE) to pulmonary arterial systolic pressure (PASP) by way of echocardiography. Whether TAPSE/PASP is reflective of invasive hemodynamics or occult shock in acute pulmonary embolism (PE) is unknown. This was a single-center retrospective study over a 3-year period of consecutive patients with PE who underwent mechanical thrombectomy and simultaneous pulmonary artery catheterization with echocardiograms performed within 24 hours before the procedure. A total of 70 patients (81% intermediate risk) had complete invasive hemodynamic profiles and echocardiograms, with TAPSE/PASP calculated. The optimal cutoff for TAPSE/PASP as a predictor of a reduced cardiac index (CI) (CI ≤2.2 L/min/m2) was 0.34 mm/mm Hg, with an area under the curve of 0.97 and sensitivity, specificity, positive predictive value, and negative predictive value of 97.3%, 90.9%, 92.3%, and 96.8%, respectively. Every 0.1 mm/mm Hg decrease in TAPSE/PASP was associated with a 0.24-L/min/m2 decrease in the CI. This relation was similar when restricted to intermediate-risk PE. The TAPSE/PASP ratio was predictive of normotensive shock with an odds ratio of 2.63 (95% confidence interval 1.42 to 4.76, p = 0.002) per unit decrease in the ratio. In conclusion, in patients with acute PE who underwent mechanical thrombectomy, TAPSE/PASP was a strong predictor of a reduced CI and normotensive shock. This means that noninvasive point-of-care assessment of hemodynamics may have added value in PE risk stratification.
PMID: 39505227
ISSN: 1879-1913
CID: 5766852

Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial

Reynolds, Harmony R; Page, Courtney B; Shaw, Leslee J; Berman, Daniel S; Chaitman, Bernard R; Picard, Michael H; Kwong, Raymond Y; Min, James K; Leipsic, Jonathon; Mancini, G B John; Budoff, Matthew J; Hague, Cameron J; Senior, Roxy; Szwed, Hanna; Bhargava, Balram; Celutkiene, Jelena; Gadkari, Milind; Bainey, Kevin R; Doerr, Rolf; Ramos, Ruben B; Ong, Peter; Naik, Sudhir R; Steg, Philippe Gabriel; Goetschalckx, Kaatje; Chow, Benjamin J W; Scherrer-Crosbie, Marielle; Phillips, Lawrence; Mark, Daniel B; Spertus, John A; Alexander, Karen P; O'Brien, Sean M; Boden, William E; Bangalore, Sripal; Stone, Gregg W; Maron, David J; Hochman, Judith S; ,
BACKGROUND/UNASSIGNED:The relationship between the extent and severity of stress-induced ischemia and the extent and severity of anatomic coronary artery disease (CAD) in patients with obstructive CAD is multifactorial and includes the intensity of stress achieved, type of testing used, presence and extent of prior infarction, collateral blood flow, plaque characteristics, microvascular disease, coronary vasomotor tone, and genetic factors. Among chronic coronary disease participants with site-determined moderate or severe ischemia, we investigated associations between ischemia severity on stress testing and the extent of CAD on coronary computed tomography angiography. METHODS/UNASSIGNED:Clinically indicated stress testing included nuclear imaging, echocardiography, cardiac magnetic resonance imaging, or nonimaging exercise tolerance test. Among those with preserved renal function who underwent coronary computed tomography angiography, we examined relationships between ischemia and CAD by coronary computed tomography angiography, overall, and by stress test modality, regardless of subsequent randomization. Core laboratories categorized ischemia as severe, moderate, mild, or none, while the extent and severity of anatomic CAD were categorized based on the modified Duke prognostic index. RESULTS/UNASSIGNED:Among 3601 participants with interpretable stress tests and coronary computed tomography angiography, ischemia severity was weakly associated with CAD extent/severity (r=0.27), with modest variability in strength of association by modality: nuclear (n=1532; r=0.40), echocardiography (n=827; r=0.15), cardiac magnetic resonance imaging (n=108; r=0.31), and exercise tolerance test (n=1134; r=0.18). The extent of infarction on nuclear imaging and echocardiography was weakly associated with CAD extent/severity. CONCLUSIONS/UNASSIGNED:Overall, ischemia severity on stress testing showed weak to moderate associations with the anatomic extent of CAD in this cohort with moderate or severe ischemia on local interpretation and controlled symptoms. REGISTRATION/UNASSIGNED:URL: https://www.clinicaltrials.gov; Unique identifier: NCT01471522.
PMCID:11658795
PMID: 39689188
ISSN: 1941-7632
CID: 5764392

Comparing Outcomes Between Advanced Practice Providers and Housestaff Teams in the Cardiac Intensive Care Unit

Zhang, Robert S; Zhang, Peter; Bailey, Eric; Ho, Alvin; Rhee, Aaron; Xia, Yuhe; Schimmer, Hannah; Bernard, Samuel; Castillo, Patricio; Grossman, Kelsey; Dai, Matthew; Singh, Arushi; Padilla-Lopez, Mireia; Nunemacher, Kayla; Hall, Sylvie F; Rosenzweig, Barry; Katz, Jason N; Link, Nathan; Keller, Norma; Bangalore, Sripal; Alviar, Carlos L
BACKGROUND/UNASSIGNED:With an increasing demand for critical care expertise and limitations in intensivist availability, innovative staffing models, such as the utilization of advanced practice providers (APPs), have emerged. OBJECTIVES/UNASSIGNED:The purpose of the study was to compare patient outcomes between APP and housestaff teams in the cardiac intensive care unit (CICU). METHODS/UNASSIGNED:This retrospective study, spanning March 2022 to July 2023, compares patient characteristics and outcomes between two CICU teams embedded in the same CICU at a large urban academic hospital: one staffed by housestaff and the other by APPs (80% physician assistants, 20% nurse practitioners) who each had approximately 1 to 2 years of experience in the CICU. The primary outcome was CICU mortality. Multivariable Cox regression analyses and Kaplan-Meier curves were used to assess the primary outcome. RESULTS/UNASSIGNED: < 0.0001). CONCLUSIONS/UNASSIGNED:Our moderately sized study demonstrated no difference in CICU or in-hospital mortality between patients managed by a housestaff team versus those managed by an APP team.
PMCID:11576500
PMID: 39569031
ISSN: 2772-963x
CID: 5758722

Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Systematic Review and Meta-Analysis

Joseph, Meghna; Krishna, Mrinal Murali; Ezenna, Chidubem; Pereira, Vinicius; Ismayl, Mahmoud; Nanna, Michael G; Bangalore, Sripal; Goldsweig, Andrew M
The present guidelines recommend dual antiplatelet therapy (DAPT) for 6 to 12 months after percutaneous coronary intervention (PCI), with recent trials assessing the safety and efficacy of shortening DAPT duration to ≤3 months. A systematic search of PubMed, Scopus, and Cochrane Central databases identified studies comparing short DAPT, followed by P2Y12i monotherapy (78% ticagrelor) versus standard 12-month DAPT in patients who underwent PCI with a drug-eluting stent. A total of 9 randomized controlled trials, including 42,770 patients (short DAPT n = 21,370, 49.96%), of whom 28,307 (66.18%) presented with acute coronary syndrome (ACS). Short DAPT significantly reduced net adverse clinical events (NACEs) (risk ratio [RR] 0.78, 95% confidence interval [CI] 0.67 to 0.91, p = 0.001, I2 = 62%), major bleeding (RR 0.54, 95% CI 0.39 to 0.73, p <0.001, I2 = 63%), and any bleeding (RR 0.55, 95% CI 0.43 to 0.72, p <0.001, I2 = 77%) at 12 months compared with 1-year DAPT. No significant differences were observed in major adverse cardiovascular/cerebrovascular events, myocardial infarction, stroke, stent thrombosis, mortality, or revascularization. Ticagrelor monotherapy after short DAPT further reduced major adverse cardiovascular/cerebrovascular events (RR 0.85, 95% CI 0.73 to 0.99, p = 0.040, I² = 22%), NACE (RR 0.74, 95% CI 0.61 to 0.89, p = 0.001, I² = 68%), and major bleeding (RR 0.56, 95% CI 0.40 to 0.78, p <0.001, I² = 71%) compared with 1-year DAPT; however, the test for subgroup interaction (Pinteraction >0.05) for clopidogrel subgroup was not significant. P2Y12i monotherapy reduced the risk of NACEs (RR 0.77, 95%CI 0.66 to 0.90, p = 0.001, I2 = 52%, Pinteraction = 0.58) and major bleeding (RR 0.44, 95%CI 0.35 to 0.55, p <0.001, I2 = 0%, Pinteraction <0.01) in the ACS cohort but not in the chronic coronary syndrome cohort. In conclusion, short DAPT for ≤3 months followed by P2Y12i monotherapy (particularly, ticagrelor) was associated with decreased NACEs and bleeding without differences in other outcomes and should be considered a favorable option in patients with either ACS or chronic coronary syndrome after PCI with a drug-eluting stent.
PMID: 39577682
ISSN: 1879-1913
CID: 5758962

Fasting prior to percutaneous cardiovascular procedures: is it time to abandon this time-honoured practice?

Bangalore, Sripal; Maqsood, Muhammad H
PMID: 39545812
ISSN: 1522-9645
CID: 5753762

Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial

Bangalore, Sripal; Rhodes, Grace; Maron, David J; Anthopolos, Rebecca; O'Brien, Sean M; Jones, Philip G; Mark, Daniel B; Reynolds, Harmony R; Spertus, John A; Stone, Gregg W; White, Harvey D; Xu, Yifan; Fremes, Stephen E; Hochman, Judith S; Ischemia Research Group, On Behalf Of The
BACKGROUND:Whether revascularisation (REV) improves outcomes in patients with three-vessel coronary artery disease (3V-CAD) is uncertain. AIMS/OBJECTIVE:Our objective was to evaluate outcomes with REV (percutaneous coronary intervention [PCI] or coronary artery bypass graft surgery [CABG]) versus medical therapy in patients with 3V-CAD. METHODS:ISCHEMIA participants with 3V-CAD on coronary computed tomography angiography without prior CABG were included. Outcomes following initial invasive management (INV) with REV (PCI or CABG) versus initial conservative management (CON) with medical therapy alone were evaluated. Regression modelling was used to estimate the outcomes if all participants were to undergo prompt REV versus those assigned to CON. Outcomes were cardiovascular (CV) death/myocardial infarction (MI), death, CV death, and quality of life. Bayesian posterior probability for benefit (Pr [benefit]) for 1 percentage point lower 4-year rates with REV versus CON were evaluated. RESULTS:Among 1,236 participants with 3V-CAD (612 INV/624 CON), REV was associated with lower 4-year CV death/MI (adjusted 4-year difference: -4.4, 95% credible interval [CrI] -8.7 to -0.3 percentage points, Pr [benefit]=94.8%) when compared with CON, with similar results for PCI versus CON (-5.8, 95% CrI: -10.8 to -0.5 percentage points, Pr [benefit]=96.4%) and CABG versus CON (-3.7, 95% CrI: -8.8 to 1.5 percentage points, Pr [benefit]=84.7%). Adjusted 4-year REV versus CON differences were as follows: death -1.2 (95% CrI: -4.7 to 2.2) percentage points, CV death -2.3 (95% CrI: -5.5 to 0.8) percentage points, with similar results for PCI and for CABG. The Pr (benefit) for death with REV (PCI or CABG) versus CON was 49-63%. The adjusted 12-month Seattle Angina Questionnaire-7 summary score differences favoured REV: REV versus CON 4.6 (95% CrI: 2.7-6.4) percentage points; PCI versus CON 3.6 (95% CrI: 1.2-5.8) percentage points and CABG versus CON 4.3 (95% CrI: 1.5-6.9) percentage points with high Pr (benefit). CONCLUSIONS:In participants with 3V-CAD, REV (either PCI or CABG) was associated with a lower 4-year CV death/MI rate and improved quality of life, with similar results for PCI versus CON and CABG versus CON. The differences in all-cause mortality between REV and CON were small with wide confidence intervals. (ClinicalTrials.gov: NCT01471522).
PMCID:11472139
PMID: 39432255
ISSN: 1969-6213
CID: 5739552